Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
A randomised double blind dose non-inferiority trial of a daily dose of 600mg versus 300mg versus 100mg of enteric coated aspirin as a cancer preventive in carriers of a germline pathological mismatch repair gene defect, Lynch Syndrome. Project 3 in the Cancer Prevention Programme (CaPP3).
创建时间：
2016-09-15
